Incidence and demography of femur fractures with and without atypical features

被引:137
作者
Feldstein, Adrianne C. [1 ,2 ]
Black, Dennis [3 ]
Perrin, Nancy [1 ]
Rosales, A. Gabriela [1 ]
Friess, Darin [4 ]
Boardman, David [2 ]
Dell, Richard [5 ]
Santora, Arthur [6 ]
Chandler, Julie M. [7 ]
Rix, Mary M. [1 ]
Orwoll, Eric [4 ]
机构
[1] Kaiser Permanente Ctr Hlth Res, Portland, OR 97227 USA
[2] Kaiser Permanente NW, Portland, OR USA
[3] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA
[4] Oregon Hlth & Sci Univ, Dept Orthoped, Portland, OR 97201 USA
[5] Kaiser Permanente So Calif, Pasadena, CA USA
[6] Merck Res Labs, Rahway, NJ USA
[7] Merck Res Labs, N Wales, PA USA
关键词
BISPHOSPHONATE; SUBTROCHANTERIC AND FEMORAL SHAFT FRACTURES; ATYPICAL FRACTURE; FEMORAL-SHAFT FRACTURES; VERTEBRAL FRACTURES; ALENDRONATE THERAPY; BISPHOSPHONATE USE; RANDOMIZED-TRIAL; OSTEOPOROSIS; WOMEN; RISK;
D O I
10.1002/jbmr.1550
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The case definition, community incidence, and characteristics of atypical femoral shaft fractures (FSFs) are poorly understood. This retrospective study utilized electronic medical records and radiograph review among women =50 years of age and men =65 years of age from January 1996 to June 2009 at Kaiser Permanente Northwest to describe the incidence rates and characteristics of subgroups of femur fractures. Fractures were categorized based on the American Society for Bone and Mineral Research (ASBMR) as atypical fracture major features (AFMs) (low force, shaft location, transverse or short oblique, noncomminuted) and AFMs with additional minor radiograph features (AFMms) (beaking, cortical thickening, or stress fracture). There were 5034 fractures in the study. The incidence rates of FSFs (without atypical features) and AFMs appeared flat (cumulative incidence: 18.2 per 100,000 person-years, 95% CI?=?16.020.7; 5.9 per 100,000 person-years, 95% CI?=?4.67.4; respectively) with 1,271,575 person-years observed. The proportion of AFMs that were AFMms increased over time. Thirty percent of AFMs had any dispensing of a bisphosphonate prior to the fracture, compared to 15.8% of the non-atypical FSFs. Years of oral glucocorticosteroid dispensing appeared highest in AFM and AFMm fractures. Those with AFMs only were older and had a lower frequency of bisphosphonate dispensing compared to those with AFMms. We conclude that rates of FSFs, with and without atypia, were low and stable over 13.5 years. Patients with only AFMs appear to be different from those with AFMms; it may be that only the latter group is atypical. There appear to be multiple associated risk factors for AFMm fractures. (c) 2012 American Society for Bone and Mineral Research.
引用
收藏
页码:977 / 986
页数:10
相关论文
共 21 条
[1]
Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]
[2]
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[3]
Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies [J].
Boonen, S ;
Laan, RF ;
Barton, IP ;
Watts, NB .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (10) :1291-1298
[4]
Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]
[5]
The impact of compliance with osteoporosis therapy on fracture rates in actual practice [J].
Caro, JJ ;
Ishak, KJ ;
Huybrechts, KF ;
Raggio, G ;
Naujoks, C .
OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) :1003-1008
[6]
Summary of meta-analyses of therapies for postmenopausal osteoporosis [J].
Cranney, A ;
Guyatt, G ;
Griffith, L ;
Wells, G ;
Tugwell, P ;
Rosen, C .
ENDOCRINE REVIEWS, 2002, 23 (04) :570-578
[7]
EPIDEMIOLOGY OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES [J].
CUMMINGS, SR ;
KELSEY, JL ;
NEVITT, MC ;
ODOWD, KJ .
EPIDEMIOLOGIC REVIEWS, 1985, 7 :178-208
[8]
Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: Results from the Fracture Intervention Trial long-term extension [J].
Ensrud, KE ;
Barrett-Connor, EL ;
Schwartz, A ;
Santora, AC ;
Bauer, DC ;
Suryawanshi, S ;
Feldstein, A ;
Haskell, WL ;
Hochberg, MC ;
Torner, JC ;
Lombardi, A ;
Black, DM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1259-1269
[9]
An outreach program improved osteoporosis management after a fracture [J].
Feldstein, Adrianne C. ;
Vollmer, William M. ;
Smith, David H. ;
Petrik, Amanda ;
Schneider, Jennifer ;
Glauber, Harry ;
Herson, Michael .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (09) :1464-1469
[10]
Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features [J].
Giusti, Andrea ;
Hamdy, Neveen A. T. ;
Dekkers, Olaf M. ;
Ramautar, Sharita R. ;
Dijkstra, Sander ;
Papapoulos, Socrates E. .
BONE, 2011, 48 (05) :966-971